330 results on '"Lanctôt, Krista L."'
Search Results
2. Sex‐specific neuropsychological correlates of apathy and depression across neurodegenerative disorders
3. Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico‐pathological study
4. Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression: observational analysis
5. Heterogeneity of Cognition in Older Adults with Remitted Major Depressive Disorder: A Latent Profile Analysis
6. Association between clinical dementia rating and clinical outcomes in Alzheimer's disease
7. Reduction of agitation and caregiver distress using a combination intervention of tetrahydrocannabinol and melatonin in dementia due to Alzheimer disease
8. Changes in Brain Glutathione in patients with mild vascular cognitive impairment
9. Investigating the effects of aerobic exercise primed anodal transcranial direct current stimulation on γ‐aminobutyric acid concentrations in mild vascular cognitive impairment
10. Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial
11. Beta to Theta Power Ratio in Electroencephalogram Periodic Components to Discriminate Mild Cognitive Impairment and Alzheimer’s Dementia
12. Characterizing PRN Use of Psychotropic Medications for Acute Agitation in Canadian LTC Residents With Dementia Before and During COVID‐19
13. Brain glutathione may be associated with white matter hyperintensities in patients with cardiovascular disease
14. Fluid Biomarkers of Neurodegeneration in Mild Cognitive Impairment: A Meta‐Analysis
15. Reduction of neuropsychiatric symptoms and associated caregiver distress using a tetrahydrocannabinol and melatonin combination in dementia due to Alzheimer’s disease
16. Changing the trajectory of Alzheimer’s disease: What is a meaningful delay in disease progression?
17. Investigating the impact of hypertension with and without diabetes on progression to Alzheimer’s disease: A clinic‐pathological study
18. Effect of tetrahydrocannabinol and melatonin combination on suicide ideation and behavior in dementia due to Alzheimer’s disease
19. Risk of motor vehicle collisions and culpability among older drivers using cannabis: a meta‐analysis
20. Profiles of modifiable dementia risk factors in later midlife: a latent class analysis
21. Reduction of apathy and caregiver distress using a combination of tetrahydrocannabinol and melatonin in dementia due to Alzheimer’s disease
22. Associations between homocysteine, tau, and neurodegenerative markers in apolipoprotein ε4 non‐carriers with clinical Alzheimer’s disease
23. Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders
24. Effect of the combination of tetrahydrocannabinol and melatonin (IGC‐AD1) on blood pressure variability in patients with mild to moderate Alzheimer’s Disease
25. Blood‐based biomarkers for predicting treatment response in the Apathy in Dementia Methylphenidate Trial 2 randomized clinical trial
26. Circulating cell‐free mitochondrial DNA (ccf‐mtDNA) and memory in mild cognitive impairment (MCI) and Alzheimer’s disease (AD)
27. Association between lipopolysaccharide, immune biomarkers and cerebral amyloid‐beta deposition in older adults with mild cognitive impairment & major depressive disorder
28. Apathy in Alzheimer’s Disease
29. A Literature Review on the Burden of Alzheimer’s Disease on Care Partners
30. Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis
31. Self- versus informant-report of cognitive decline in mild cognitive impairment: Concordance with cognitive and functional performance.
32. No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes
33. Cytochrome P450-soluble epoxide hydrolase derived linoleic acid oxylipins and cognitive performance in type 2 diabetes
34. Attentional impairments to novel images in dementia
35. Contributors
36. Association of sulfonylureas with the risk of dementia: A population‐based cohort study
37. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer’s Disease
38. Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)
39. Identifying factors influencing cognitive outcomes after anodal transcranial direct current stimulation in older adults with and without cognitive impairment: A systematic review
40. Risk of Motor Vehicle Collisions and Culpability among Older Drivers Using Cannabis: A Meta-Analysis
41. Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment‐related aspects of apathy from depression in neurocognitive disorders
42. Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in Stroke
43. Association of sodium-glucose cotransporter-2 inhibitors with time to dementia: a population-based cohort study
44. Association of sodium-glucose cotransporter-2 inhibitors with time to dementia: a population-based cohort study
45. Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study
46. Variability of response to exercise‐primed tDCS in those with mild cognitive impairment and Alzheimer’s disease (the EXPRESS study): a preliminary analysis
47. Lipid oxidation as a marker of apathy and executive dysfunction in patients at risk of vascular cognitive impairment
48. Heterogeneity of response to methylphenidate in apathetic patients in the ADMET 2 Trial
49. Association of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors with time to dementia: a population‐based cohort study
50. Boswellic acids (K‐Vie ™ ) improves clinical cognitive scores and reduces systemic inflammation in patients with mild to moderate Alzheimer’s disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.